Sickle Cell Patient with Severe Anemia Rapidly Improves with Voxelotor, Case Study Shows
News
Global Blood Therapeutics (GBT) reported a case study in which a sickle cell disease (SCD) patient was granted compassionate access to the company’s ongoing Phase 3 HOPE study of voxelotor ... Read more